Lincoln Pharma inks pact with Swiss-based firm for Tinnitus

12 Jan 2012 Evaluate

Lincoln Pharmaceuticals (LPL), a world class pharmaceutical company has entered into an agreement with Switzerland-based Phafag AG, for its Caroverine molecule for the treatment of Tinnitus-commonly known as “ringing in the ear”, a condition where inner hair cells get damaged causing continuous depression, anxiety and insomnia in patients. Millions of people around the world suffer from Tinnitus. It becomes the first company in India to introduce a cure for Tinnitus as Tinnex injection using Caroverine.

With a large number of people suffering from Tinnitus and not much is being done about it, the company invested in the R&D and took the first steps towards bringing the patients suffering from Tinnitus closer to treatment. The company developed Caroverine injection under research and development collaboration with Phafag AG to introduce Tinnex.

Tinnex Injection is a slow intravenous infusion. The dosage differs from patient to patient and depends on the severity.

Lincoln Pharmaceuticals has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad. The plant spreads across 30,000 square meters.

Lincoln Pharma Share Price

617.50 -0.15 (-0.02%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.